Literature DB >> 7941250

Use of the serum neutralisation test for equine viral arteritis with different virus strains.

Y Fukunaga1, T Matsumura, T Sugiura, R Wada, H Imagawa, T Kanemaru, M Kamada.   

Abstract

Serum cross neutralisation tests were conducted with a recent American isolate (84KY-A1) and a European isolate, (Wroclaw-2) and compared with the prototype and modified viruses of the Bucyrus strain of equine arteritis virus by using virus specific immune horse sera. The modified Bucyrus strain was neutralised and showed high neutralisation titres with all the immune sera. The prototype Bucyrus strain was also substantially neutralised, followed by the 84KY-A1 strain. As a result of the tests with the modified Bucyrus strain as the antigen, 20 seropositive horses were discovered among home-bred horses which had no previous record of clinical equine viral arteritis. Heat inactivation of the sera at 62 degrees C for 30 minutes caused the disappearance of all but the most positive reactions. When the prototype Bucyrus strain was used instead of the modified virus, no positive reactions were detectable. A serological survey, using the Bucyrus strain in a microtitre neutralisation test, was conducted with 1656 horse sera collected between 1988 and 1990 in Japan. The test disclosed only eight foreign-bred horses positive to the virus; they had been imported as competition horses. No circumstantial evidence of an effect of such horses as a source of infection for horse populations free of the virus was obtained.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7941250     DOI: 10.1136/vr.134.22.574

Source DB:  PubMed          Journal:  Vet Rec        ISSN: 0042-4900            Impact factor:   2.695


  9 in total

1.  Comparison of nucleic and amino acid sequences and phylogenetic analysis of the Gs protein of various equine arteritis virus isolates.

Authors:  N Lepage; G St-Laurent; S Carman; D Archambault
Journal:  Virus Genes       Date:  1996       Impact factor: 2.332

2.  Expression cloning and humoral immune response to the nucleocapsid and membrane proteins of equine arteritis virus.

Authors:  A Kheyar; S Martin; G St-Laurent; P J Timoney; W H McCollum; D Archambault
Journal:  Clin Diagn Lab Immunol       Date:  1997-11

3.  Genetic and amino acid analysis of the GL protein of Canadian, American and European equine arteritis virus isolates.

Authors:  G St-Laurent; N Lepage; S Carman; D Archambault
Journal:  Can J Vet Res       Date:  1997-01       Impact factor: 1.310

4.  Generation of a candidate live marker vaccine for equine arteritis virus by deletion of the major virus neutralization domain.

Authors:  Javier Castillo-Olivares; Roeland Wieringa; Tamás Bakonyi; Antoine A F de Vries; Nick J Davis-Poynter; Peter J M Rottier
Journal:  J Virol       Date:  2003-08       Impact factor: 5.103

5.  Nucleotide sequence and genetic analysis of the leader region of Canadian, American and European equine arteritis virus isolates.

Authors:  A Kheyar; G St-Laurent; M Diouri; D Archambault
Journal:  Can J Vet Res       Date:  1998-07       Impact factor: 1.310

6.  A DNA aptamer efficiently inhibits the infectivity of Bovine herpesvirus 1 by blocking viral entry.

Authors:  Jian Xu; Xixi Zhang; Shuanghai Zhou; Junjun Shen; Dawei Yang; Jing Wu; Xiaoyang Li; Meiling Li; Xiufen Huang; Joshua E Sealy; Munir Iqbal; Yongqing Li
Journal:  Sci Rep       Date:  2017-09-18       Impact factor: 4.379

7.  Equine arteritis virus.

Authors:  A L Glaser; E D Chirnside; M C Horzinek; A A de Vries
Journal:  Theriogenology       Date:  1997-04-15       Impact factor: 2.740

8.  Detection of equine arteritis virus (EAV) by polymerase chain reaction (PCR) and differentiation of EAV strains by restriction enzyme analysis of PCR products.

Authors:  K Sekiguchi; S Sugita; Y Fukunaga; T Kondo; R Wada; M Kamada; S Yamaguchi
Journal:  Arch Virol       Date:  1995       Impact factor: 2.574

9.  Development and evaluation of an ELISA using recombinant fusion protein to detect the presence of host antibody to equine arteritis virus.

Authors:  E D Chirnside; P M Francis; A A de Vries; R Sinclair; J A Mumford
Journal:  J Virol Methods       Date:  1995-07       Impact factor: 2.014

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.